Back to BALYASNY ASSET MANAGEMENT L.P. BALYASNY ASSET MANAGEMENT L.P.

LXEOLXEO
5 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.'s holdings in LEXEO THERAPEUTICS INC

BALYASNY ASSET MANAGEMENT L.P. holds 2.4M shares of LXEO (LEXEO THERAPEUTICS INC), worth $11.2M as of 2026-Q2. The position was increased (+51.8% shares). LXEO represents 0.0% of BALYASNY ASSET MANAGEMENT L.P.'s portfolio.

Current Value

$11.2M

Current Shares

2.4M

Total Value Change

-$4.9M

Total Shares Change

-1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.4M
+51.8%
$11.2M0.0%$4.66
39
2026-Q1
Decreased
1.6M
-2.8%
$9.1M0.0%$7.07
0
2025-Q4
Decreased
1.6M
-58.2%
$16.2M0.0%$9.74
0
2025-Q3
Decreased
3.9M
-2.4%
$26M0.0%$6.66
0
2025-Q2
New
4M
-
$16.1M0.0%$4.12
39

Other major holders of LXEO: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used